Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study

AIM: To compare the risks of hospitalization for heart failure (HHF) associated with sulfonylurea (SU), dipeptidyl peptidase-4 inhibitor (DPP-4i), and thiazolidinedione (TZD) as add-on medications to metformin (MET) therapy using the data of Korean adults with type-2 diabetes from the Korean Nationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su Jin, Ha, Kyoung Hwa, Lee, Jung Hyun, Lee, Hokyou, Kim, Dae Jung, Kim, Hyeon Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370220/
https://www.ncbi.nlm.nih.gov/pubmed/30742667
http://dx.doi.org/10.1371/journal.pone.0211959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370220/
https://www.ncbi.nlm.nih.gov/pubmed/30742667
http://dx.doi.org/10.1371/journal.pone.0211959

Ejemplares similares